AG2R LA Mondiale Gestion D Actifs Makes New Investment in Baxter International Inc. $BAX

Key Points

• AG2R LA Mondiale Gestion D Actifs has invested approximately $1.02 million in Baxter International Inc. by acquiring 29,835 shares, reflecting growing interest from large investors in the company.
• Baxter International recently reported an EPS of $0.59, slightly missing analysts' estimates, while projecting a Q3 2025 EPS guidance of 0.580-0.620.
• The company announced a quarterly dividend of $0.17 per share, indicating a 2.8% yield, despite a negative payout ratio of -226.67%.

AG2R LA Mondiale Gestion D Actifs bought a new stake in shares of Baxter International Inc. (NYSE:BAX - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 29,835 shares of the medical instruments supplier's stock, valued at approximately $1,021,000.

Other large investors also recently bought and sold shares of the company. Raiffeisen Bank International AG raised its holdings in Baxter International by 24.9% in the first quarter. Raiffeisen Bank International AG now owns 95,668 shares of the medical instruments supplier's stock worth $3,229,000 after buying an additional 19,081 shares during the last quarter. New York State Common Retirement Fund raised its holdings in shares of Baxter International by 30.9% during the first quarter. New York State Common Retirement Fund now owns 623,403 shares of the medical instruments supplier's stock valued at $21,339,000 after purchasing an additional 147,155 shares during the last quarter. Dodge & Cox raised its holdings in shares of Baxter International by 2.1% during the first quarter. Dodge & Cox now owns 51,458,925 shares of the medical instruments supplier's stock valued at $1,761,439,000 after purchasing an additional 1,081,631 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Baxter International by 248.3% during the first quarter. GAMMA Investing LLC now owns 11,326 shares of the medical instruments supplier's stock valued at $388,000 after purchasing an additional 8,074 shares during the last quarter. Finally, SG Americas Securities LLC grew its position in Baxter International by 352.6% during the first quarter. SG Americas Securities LLC now owns 74,094 shares of the medical instruments supplier's stock valued at $2,536,000 after buying an additional 57,723 shares during the period. 90.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on BAX. Wells Fargo & Company cut their target price on shares of Baxter International from $33.00 to $24.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. Wall Street Zen lowered shares of Baxter International from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Morgan Stanley reduced their target price on shares of Baxter International from $28.00 to $27.00 and set an "underweight" rating on the stock in a research note on Tuesday, July 15th. UBS Group reduced their target price on shares of Baxter International from $35.00 to $24.00 and set a "neutral" rating on the stock in a research note on Monday, August 4th. Finally, Stifel Nicolaus reissued a "hold" rating and issued a $25.00 target price (down previously from $36.00) on shares of Baxter International in a research note on Monday, August 4th. Three analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $30.11.

Baxter International Stock Up 0.3%

Baxter International stock traded up $0.08 during midday trading on Tuesday, hitting $23.88. 5,747,076 shares of the company's stock were exchanged, compared to its average volume of 5,917,332. Baxter International Inc. has a 12 month low of $21.33 and a 12 month high of $40.49. The company has a market cap of $12.27 billion, a PE ratio of -79.60, a P/E/G ratio of 0.78 and a beta of 0.61. The company has a debt-to-equity ratio of 1.30, a quick ratio of 1.49 and a current ratio of 2.30. The firm has a 50-day moving average of $25.35 and a two-hundred day moving average of $29.20.

Baxter International (NYSE:BAX - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 earnings per share for the quarter, missing analysts' consensus estimates of $0.60 by ($0.01). The firm had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $2.82 billion. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The firm's quarterly revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.68 earnings per share. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. As a group, analysts expect that Baxter International Inc. will post 2.48 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 1st. Investors of record on Friday, August 29th will be paid a $0.17 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.68 dividend on an annualized basis and a yield of 2.8%. Baxter International's dividend payout ratio (DPR) is -226.67%.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.